Mohamed Genead
Chief Executive Officer en Aviceda Therapeutics, Inc. .
Perfil
Mohamed A.
Genead is the founder of Aviceda Therapeutics, Inc. He is currently the Chairman, President & Chief Executive Officer of Aviceda Ophthalmics, Inc. He was previously the Director-Center of Retina Degenerative Diseases at the University of Illinois and the Chief Medical Officer at Ocugen, Inc. In 2017, he briefly served as the Chief Medical Officer at Gensight Biologics SA.
Cargos activos de Mohamed Genead
Empresas | Cargo | Inicio |
---|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The private company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Chief Executive Officer | - |
Antiguos cargos conocidos de Mohamed Genead.
Empresas | Cargo | Fin |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 01/11/2017 |
University of Illinois | Corporate Officer/Principal | - |
OCUGEN, INC. | Chief Tech/Sci/R&D Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
OCUGEN, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The private company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Bolsa de valores
- Insiders
- Mohamed Genead